Tactile Change Blindness Induced by Tactile and Visual Distractors

Change blindness studies have revealed people's inability to detect changes between two consecutively presented scenes when they are separated by a distractor. This failure has been reported within vision, audition, and touch but also crossmodally. In particular, participants' performance in detecting changes in position between two tactile scenes is impaired not only when a tactile mask is introduced between the two to-be-compared displays but also when a visual mask is used instead. Interestingly, with similar procedure, there is no effect of auditory masks on a tactile task or of tactile masks on a visual task (Auvray et al., 2007, 2008; Gallace et al., 2006). Such crossmodal change blindness effect also occurs when participants perform a different task. In a recent experiment, participants had to detect changes in the frequency of presentation of tactile stimuli. The two to-be-compared sequences of three tactile stimuli were presented either at a same or at a different rate. They were presented either consecutively, separated by an empty interval, a tactile, visual, or auditory mask. The visual and tactile masks significantly impaired participants' performance whereas the auditory mask had no effect on performance. These findings are discussed in relation to the crossmodal nature of attention

Effect of Subcultivation of Human Bone Marrow Mesenchymal Stem on their Capacities for Chondrogenesis, Supporting Hematopoiesis, and Telomea Length

Effects of subcultivation of human bone marrow mesenchymal stem cells on their capacities for chondrogenesis and supporting hematopoiesis, and telomea length were investigated. Mesenchymal stem cells were isolated from human bone marrow aspirates and subcultivated several times at 37℃ under a 5% CO2 atmosphere employing DMEM medium containing 10% FCS up to the 20th population doubling level (PDL). The ratio of CD45- CD105+ cells among these cells slightly increased as PDL increased. However, there was no marked change in the chondrogenic capacity of these cells, which was confirmed by expression assay of aggrecan mRNA and Safranin O staining after pellet cell cultivation. The change in capacity to support hematopoiesis of cord blood cells was not observed among cells with various PDLs. On the other hand, telomere length markedly decreased as PDL increased at a higher rate than that at which telomere length of primary mesenchymal stem cells decreased as the age of donor increased

Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue

A differentiation method of human bone marrow mesenchymal stem cells (MSCs) to chondrocytes was developed for the construction of a three-dimensional (3D) cartilage tissue. The adhesive cells, which were isolated from a human bone marrow aspirate were embedded in type I collagen in a poly-l-lactate-glycolic acid copolymer (PLGA) mesh and cultivated for 4 week together with growth factors. The degree of cellular differentiation was estimated by quantitative RT-PCR of aggrecan and type II collagen mRNAs and by staining with Safranin O. The 3D culture showed a higher degree of differentiation even without growth factors than the conventional pellet culture with growth factors, namely, dexamethasone and transforming growth factor (TGF)-β 3. The 3D culture for 2 week with the combined addition of dexamethasone, TGF-β 3, and insulin-like growth factor (IGF)-I reached a 30% expression of aggrecan mRNA compared with that in primary human chondrocytes, while the aggrecan mRNA expression in the conventional pellet culture was less than 2%. The sequential two-step differentiation cultivation, during which the cells were cultivated in 3D for 1 week after the conventional two-dimensional (2D) culture for 1 week, could markedly accelerate the expression of aggrecan mRNA compared with the 3D cultivation for 2 week

雌ラットにおいて生殖腺の状態とエストロゲン環境が視床下部オキシトシン遺伝子発現および血清オキシトシンレベルに及ぼす影響

Oxytocin (OT) and its receptor (OTR) play various roles in the central and peripheral regulation of appetite and body weight. Previously, we have shown that the administration of OT markedly decreased appetite and body weight gain in ovariectomized (OVX) obese rats. In addition, recent studies have shown that the endogenous OT system is also affected by endogenous or exogenous estrogen. In this study, we showed that ovariectomy decreased rats' hypothalamic OT/OTR mRNA and serum OT levels, but did not affect their visceral fat OTR mRNA levels. The chronic administration of estradiol (E2) abrogated these ovariectomy-induced changes; i.e., it increased the rats' hypothalamic OT/OTR mRNA and serum OT levels, and may be associated with reductions in food intake and body weight gain. In addition, acute E2 administration increased the rats' hypothalamic OTR mRNA and serum OT levels, but did not affect their hypothalamic OT mRNA levels. Taken together, these results suggest that endogenous OT and/or OTR expression might be positively regulated by E2 and that the suppressive effects of E2 on appetite and body weight gain might be mediated, at least in part, by the OT system. Thus, we consider that OT might be a target hormone to pursue subsequent interventions of menopause for menopause-induced metabolic disorders

Effects of oxytocin in postmenopausal rats

Recent studies have revealed that the administration of oxytocin has beneficial effects on the regulation of body weight, food intake, and metabolic functions, especially in obese individuals. Obesity is common in women after the menopause and drives many components of metabolic syndrome. Weight gain in menopausal women has been frequently reported. Although obesity and associated metabolic disorders are frequently observed in peri- and postmenopausal women, there are few medical interventions for these conditions. In this study, we evaluated the effects of chronic oxytocin administration on appetite, body weight, and fat mass in peri- and postmenopausal female rats. Sixteen naturally premenopausal or menopausal rats were intraperitoneally injected with oxytocin (1,000 μg/day) for 12 days. The daily changes in their body weight and food intake were measured at the same time as the oxytocin and vehicle injections. Intraperitoneally administering oxytocin for 12 days significantly reduced food intake, body weight, and visceral adipocyte size. In addition, oxytocin administration caused reductions in serum triglyceride and low-density lipoprotein-cholesterol levels, while it did not disturb hepatic or renal functions or locomotor activity. This is the first study to show the effects of oxytocin on the metabolic and feeding functions of peri- and postmenopausal female rats. Oxytocin might be a useful treatment for metabolic disorders caused by the menopause or aging

Early Spectroscopy of the 2010 Outburst of U Scorpii

We present early spectroscopy of the recurrent nova U~Sco during the outburst in 2010. We successfully obtained time-series spectra at $t_{\rm d}=$0.37--0.44~d, where $t_{\rm d}$ denotes the time from the discovery of the present outburst. This is the first time-resolved spectroscopy on the first night of U Sco outbursts. At $t_{\rm d}\sim 0.4$~d the H$\alpha$ line consists of a blue-shifted ($-5000$ km s$^{-1}$) narrow absorption component and a wide emission component having triple peaks, a blue ($\sim -3000$ km s$^{-1}$), a central ($\sim 0$ km s$^{-1}$) and a red ($\sim +3000$ km s$^{-1}$) ones. The blue and red peaks developed more rapidly than the central one during the first night. This rapid variation would be caused by the growth of aspherical wind produced during the earliest stage of the outburst. At $t_{\rm d}=1.4$~d the H$\alpha$ line has a nearly flat-topped profile with weak blue and red peaks at $\sim \pm 3000$ km s$^{-1}$. This profile can be attributed to a nearly spherical shell, while the asphericity growing on the first night still remains. The wind asphericity is less significant after $t_{\rm d}=9$ d.Comment: 5 pages, 3 figures, Accepted for publication of PASJ Letter

Application of AmpFlSTR ProfilerTM PCR Amplification kit for personal identification of a putrefied cadaver

A putrefied cadaver of q middle-aged woman was found drifting in the “Kii” water course. Autopsy findings indicated that the postmortem duration was about one week, and the cause of death was assumed to be drowning. In this case, a nail was collected as a sample for personal identification. After five months of police investigation, persons thought to be her family, husband and child, were found. A combination of D1S80 and the short tandem repeat (STR) typing system using an AmpFlSTR ProfilerTM PCR Amplification kit was performed for identification. Nine STRs (D3S1358, vWA, FGA, TH01, TPOX, CSF1PO, D5S818, D13S317 and D7S820) and Amelogenin were analyzed by this kit. Those DNA typings successfully confirmed the family relation for personal identification of the cadaver. This analysis system may be useful for identification of a decomposed cadaver

Control of synaptic transmission in the CNS through endocannabinoid-mediated retrograde signaling

Psychological and physiological effects of marijuana are caused by binding of its active component (Δ9-tetrahydrocannabinol) to cannabinoid receptors. The cannabinoid receptors belong to a family of G protein-coupled seven-transmembrane-domain receptors, and consist of type 1 (CBl) and type 2 (CB2) receptors with different distributions (Matsuda et al., 1990; Munro et al., 1993; Felder and Glass, 1998). The CBl receptor is expressed in the CNS, whereas the CB2 receptor is found in the immune system of the periphery (Klein et al., 1998). Activation of the CBl receptor induces various effects on neural functions (Di Marzo et al, 1998; Felder and Glass, 1998), including suppression of neurotransmitter release (Gifford and Ashby, 1996; Ishac et al., 1996; Shen et al., 1996; Katona et al, 1999; Hoffman and Lupica, 2000). Several molecules are identified as candidate endogenous ligands for cannabinoid receptors (endocannabinoids). Arachidonylethanolamide (anandamide) and 2-arachidonoylglycerol (2-AG), two major endocannabinoids, are reported to be synthesized from membrane phospholipids in an activity- and a Ca2+-dependent manner (Cadas et al, 1996; Stella et al, 1997; Di Marzo et al, 1998; Bisogno et al, 1999; PiomeUi et al, 2000). It is thought that they can diffuse out across the cell membrane. The released endocanabinoids are removed from the extracellular space through uptake and enzymatic degradation (Mechoulam et al, 1998). All these findings suggest that endocannabinoids can work as a diffusible and short-lived mediator that is released from activated neurons, binds to cannabinoid receptors on neighboring neurons to modulate their functions. Recent electrophysiological studies have revealed that endocannabinoids play an important role in retrograde modulation of synaptic transmission in the CNS (Kreitzer and Regehr, 2001b; Maejima et al, 2001a; Ohno-Shosaku et al, 2001; Wilson and NicoU, 2001). Endocannabinoids are released from postsynaptic neurons in response to either depolarization or activation of Gq/11-coupled receptors such as group I metabotropic glutamate receptors (mGluRs) and M1/M3 muscarinic acetylcholine receptors. The released endocannabinoids then activate presynaptic cannabinoid receptors and suppress transmitter release (Maejima et al, 2001b; Alger, 2002; Kano et al, 2002; Kreitzer and Regehr, 2002; Wilson and Nicoll, 2002; Freund et al, 2003; Kano et al., 2003; PiomelU, 2003). Thus, the endocannabinoid signaling is an important mechanism by which postsynaptic neuronal activity can retrogradely influence presynaptic functions. In this review, we introduce recent electrophysiological studies on endocannabinoidmediated retrograde modulation and discuss its possible physiological roles in the CNS.Dendritic neurotransmitter release, edited by Mike Ludwig, Springer, c2005, 269-281, (A part of the memoirs